
Cancer genomic testing – Jamal Tamer’s story
Learn about the importance of genomic testing in treating cancer, and hear from patient Jamal Tamer about the real-world impact it can have.
moreLearn about the importance of genomic testing in treating cancer, and hear from patient Debbie Rhea about the real-world impact it can have.
moreHow data can improve and save lives, and why it matters during the COVID-19 crisis and beyond.
moreMobile blood draw programs bring comprehensive genetic profiling and personalised care to cancer patients – the hidden victims of the pandemic
moreGeorge Gauthier reflects on the extraordinary 30-year journey Roche has travelled in breast cancer, and the hugely exciting potential destinations of the future.
moreWith a shared dedication to bring innovative treatments to SMA patients, the SMA Foundation, PTC Therapeutics and Roche show the power of collaboration.
moreRoche scientist Hasani Ratni shares what he believes that to be an exceptional scientist, you have to break some rules and believe the impossible is possible.
moreLearn how we are partnering with healthcare systems around the world to improve cancer care and lay the groundwork for personalised healthcare.
moreSARS CoV-2 infections often go without symptoms. Antibody tests can identify individuals who have been exposed to the virus. Learn how this works.
moreIn the race to detect and treat COVID-19, biotech, government and academia are joining forces to battle a disease that knows no borders.
moreBroad access to reliable coronavirus testing is essential to an outbreak containment strategy.
moreHCC is known as a ‘silent killer’ as the symptoms often appear too late for curative treatments. Learn more about the signs, symptoms and risk factors.
moreGlobal Head of Pharma Partnering James Sabry is excited to embrace the potential of external innovation and innovative partners.
moreOur organisation has more than 2,200 scientists at seven Roche Innovation Centers spanning each major continent
moreMartin Strahm talks about the idea, the potential and the limitations of quantum computers.
moreAll you need to know about the people and the important work at Roche Pharma Research and Early Development (pRED) Oncology as we discover the future in cancer care.
moreAI could change the way ophthalmologists diagnose eye conditions like diabetic macular edema
moreWhen everyday counts, data makes a meaningful difference for patients
moreOver 100 years of partnerships to make a sustainable difference for communities in which we operate and beyond.
moreHow patient partnership is shaping the future of research and clinical development for Huntington’s disease.
moreHepatitis B is responsible for more than 800,000 deaths a year. Roche is working on a cure.
moreThe haemophilia community is united and strong. Find out more about the haemophilia community and progress being made in the field from Brian O’Mahony, Chief Executive of the Irish Haemophilia Society.
moreAs multidrug resistant strains of bacteria are posing a growing threat to human health worldwide, our scientists are working hard on the next generation of antibiotics and diagnostic tests.
moreAntimicrobial resistance is a global and continuously raising global health challenge. Here’s what we are doing to address this problem.
morePartnering builds on our culture, one in which we listen to a potential partner and structure a collaboration that meets both parties’ needs.
more